Table 1.
Participant demographics.
| Rt-AD | Sym-AD | Lt-AD | Bonferroni post hoc | |||
|---|---|---|---|---|---|---|
| p Rt-AD vs Symmetric-AD | p Rt-AD vs Lt-AD | p Sym-AD vs Lt-AD | ||||
| N | 32 | 173 | 38 | |||
| Age | 65 ± 9 | 68 ± 11 | 68 ± 7 | 1.000 | 1.000 | 0.909 |
| Gender F:M | 22:10 | 94:79 | 21:17 | 0.552 | 0.978 | 1.000 |
| Education | 12 ± 4 | 12 ± 5 | 12 ± 5 | 1.000 | 1.000 | 0.900 |
| APOE4 carrier | 10 (36%) | 90 (56%) | 13 (39%) | 0.196 | 1.000 | 0.270 |
| Vascular risk factors | ||||||
| Hypertension | 14 (44%) | 70 (41%) | 16 (42%) | 1.000 | 1.000 | 1.000 |
| Diabetes | 1 (3%) | 28 (16%) | 5 (13%) | 0.164 | 0.626 | 1.000 |
| Hyperlipidemia | 10 (31%) | 45 (26%) | 4 (37%) | 1.000 | 1.000 | 0.534 |
| Handedness | ||||||
| Left-handed | 0 (0%) | 3 (2%) | 1 (3%) | 1.000 | 1.000 | 1.000 |
AD, Alzheimer’s disease; aMCI, amnestic mild cognitive impairment; Lt-AD, AD with left focal atrophy; Rt-AD, AD with right focal atrophy; Sym-AD, AD with symmetric atrophy